Dalrada Technology Group, Inc.

dalrada.com

What Do They Do?

Provides prescription pharmacy and infusion services, diagnostic testing, and healthcare training to patients and healthcare providers.

How Do They Make Money?

Customers are invoiced on contractual schedules; products are tied to delivery or pickup, many services to completion, and DepTec and Bothof jobs earn money as work progresses.

revenue

Segment	Share	Revenue
Unrelated Parties	92%
Related Parties	8.3%

Who Are Their Customers?

Pharmacy and infusion customers receive prescription and infusion services, while hospitals and home-health facilities use trained assistants supplied through the education business. Construction customers include residential and commercial projects; door-store customers include contractors, designers and residential buyers.

Do Revenues Turn Into Profits?

No. It lost $24.6M in FY2025.

Operating income, FY2025

−101% of revenue

▼ −24% (Loss) vs FY2024 (−$26.8M, −135%)

Net income, FY2025

−121% of revenue

▼ −15% (Loss) vs FY2024 (−$28.9M, −146%)

Free cash flow, FY2025

−90% of revenue

▲ +121% (Loss) vs FY2024 (−$8.3M, −42%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q3 FY2026, the three months to Mar 31, 2026

Revenue: ▼ −44%; vs $4.6M in Q3 FY2025
Net income: ▲ +3% (Loss); vs −$4.2M in Q3 FY2025

Unrelated Parties share of revenue vs 89.5% in Q3 FY2025

Nov 6, 2025 Chief financial officer resigned Kyle McCollum resigned effective immediately; the company was seeking a successor.

Growing. Revenue grew 6.0x in 4 years, from $3.4M in FY2021 to $20.3M in FY2025, about 56% a year.

Revenue over time

Unrelated Parties Related Parties

$25M$12.5M$0

FY2024 FY2025

Comments